about
P1343
Structural variants of human T200 glycoprotein (leukocyte-common antigen)Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigensDurable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantationAllogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNACD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome.Targeted therapies for the myeloid leukaemias.Expression of the T200 family of glycoproteins in canine malignant lymphomaA canine lymphocyte surface antigen detectable by a monoclonal antibody (DT200).Protein-tyrosine phosphatase MEG2 is expressed by human neutrophils. Localization to the phagosome and activation by polyphosphoinositides.Pretargeted radioimmunotherapy for hematologic and other malignanciesOptical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibody.Protein tyrosine phosphatases as potential therapeutic targets.Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodiesResponse of simian virus 40 (SV40)-transformed, cultured human marrow stromal cells to hematopoietic growth factors.Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.The use of radioimmunoconjugates in stem cell transplantation.Characterization of Monoclonal Antibodies against Human Leukocyte Common Antigen (CD45)Human cell surface glycoprotein related to cell proliferation is the receptor for transferrinAntibody-based treatment of acute myeloid leukaemia.Implantation site in normal pregnancy. A study with monoclonal antibodiesMonoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experiencePhenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissuesPhenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissuesEstablishment and characterisation of an Epstein-Barr virus negative B immunoblastic lymphoma cell line.CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit liganMonoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.Molecular complexity of leukocyte surface glycoproteins related to the macrophage differentiation antigen Mac-1.Human dendritic cells. Enrichment and characterization from peripheral blood.Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.The cutaneous infiltrates of leprosy. A transmission electron microscopy study.Identification of shared antigenic determinants of the putative human T lymphocyte antigen receptorThe subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigensIdentification of the sequence required for expression of the 2H4 epitope on the human leukocyte common antigens.CD8+ T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuliIntegrity of the exon 6 sequence is essential for tissue-specific alternative splicing of human leukocyte common antigen pre-mRNA.Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.Organization of the Ly-5 gene.Radioimmunotherapy-based conditioning regimens for stem cell transplantation
P2860
Q28115267-D7A111E6-1C9C-4679-B24D-BE5F7ADE9462Q28647265-DF192A76-2673-4830-A78E-7307A9ECC793Q33398529-B206789B-2424-4EA0-B4FA-AC273168A97AQ33560410-AF946696-F9EE-4B96-8EBB-3E8D1EFE7915Q33561177-EA4A61CD-0D2C-4B94-985F-8A115C4F9FEDQ33671680-CB2D2709-D05A-415C-A5D5-6F5CCD042621Q34022682-4AEE0835-4358-4CBC-B010-A819F7FEE5CDQ34074884-92DACB46-97E4-4278-A2C4-304CA74DB84CQ34080420-BE0DD3C6-1D9C-49E2-9673-A43736A2677FQ34080435-CA85EAD8-C074-4746-98ED-E8EAFD7A04ADQ34102109-DEE7E60F-7338-4CB8-9C16-FE8E8D1B16CAQ34113941-497AA59C-C49F-49DB-A816-0F1541312C77Q34149984-AD47A804-59A9-4C74-B195-F679E613FF87Q34295063-6407EDA8-92F9-421D-9C3B-340625AF0875Q34373873-EB595F73-2891-4432-A5E4-E743CF5261E9Q34566713-4F230D50-EC93-4D92-8DED-80D44D28131DQ34612119-F22A285B-BC1A-4779-A9A8-8445AC2E13E5Q34679582-F69A0761-D75C-467A-993F-81C55D19C6CCQ35000954-1BECD141-F5D4-45A1-8D7D-D83E8F4E5BBAQ35362960-7013F73C-4183-480C-B585-3B9F081B661EQ35609792-001A993D-EF94-4DE5-90B3-FAD9484B02A8Q35834895-8D4401DE-089D-4A72-BEBC-4CE2E898A2E5Q35835090-35BF9D0D-7158-4663-9894-F407F21A99B0Q35835460-4D5F53EC-811D-43C0-AEAE-B03BD1C76E42Q35858079-EE6CC9D9-C384-43A0-9934-3203E99050ADQ35982370-0186DAFB-7624-4AD3-ACD6-7995DC6F7C8CQ36230285-6BB63DF6-504C-4528-B335-E6ACE131E9E5Q36282608-5ACE5B93-59EB-467D-B42D-24D4CF92F89CQ36345840-798AB8E0-82EB-461F-B9CF-650929E69D39Q36346337-DE766CEC-3A97-47BC-B032-BD77C03E5A13Q36347625-2E6ECC51-5BB8-4EBF-AAA7-071FD0268489Q36349012-BCC67814-23E9-4D34-AE44-8261887DA337Q36349398-0597CDF4-7F8A-4FDD-B8B6-B728D2F7E664Q36354316-2746569A-EBCE-4207-A02E-4C1B9DF3637BQ36357585-050CEB40-00EA-4495-B669-C2B06B3161B4Q36730988-25B49D4C-0661-4D8F-B04A-CC0DAC2D921DQ36762943-8BB5CC2A-CFEC-4521-867D-9E6EE7EE38CEQ36814661-94C3718D-5707-4C34-9224-9CECA7CFBE7FQ36849285-9C91350B-41D5-46E9-9254-B419B35D6263Q37125119-F11C016D-E225-4189-AC5A-7F3FA5B6BF94
P2860
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Human homologue of murine T200 glycoprotein.
@ast
Human homologue of murine T200 glycoprotein.
@en
type
label
Human homologue of murine T200 glycoprotein.
@ast
Human homologue of murine T200 glycoprotein.
@en
prefLabel
Human homologue of murine T200 glycoprotein.
@ast
Human homologue of murine T200 glycoprotein.
@en
P2860
P356
P1476
Human homologue of murine T200 glycoprotein
@en
P2093
H A Battifora
I S Trowbridge
P2860
P304
P356
10.1084/JEM.152.4.842
P407
P4510
P50
P577
1980-10-01T00:00:00Z